New vac­cine ef­fec­tively treats gon­or­rhoea

The Star Early Edition - - HEALTH -

EX­PERTS have an­nounced a new vac­cine to pro­tect against the sex­u­ally trans­mit­ted dis­ease, gon­or­rhoea. The treat­ment is based on a menin­gi­tis vac­cine and was tested on 15 000 par­tic­i­pants in a study.

The re­sults come days af­ter the World Health Or­gan­i­sa­tion warned that gon­or­rhoea was evolv­ing to be­com­ing un­treat­able. The in­fec­tion, which af­fects around 78 mil­lion peo­ple an­nu­ally, was eas­ily treat­able with an­tibi­otics.

At least three peo­ple world­wide have al­ready been in­fected with to­tally un­treat­able strains of gon­or­rhoea.

Now sci­en­tists have shown that ex­po­sure to the meningo­coc­cal group B jab dur­ing a mass vac­ci­na­tion cam­paign in New Zealand re­duced gon­or­rhoea cases by 31%.

Dr He­len Pe­tousisHar­ris, of Auck­land Univer­sity, says this is the first time the vac­cine has shown any pro­tec­tion against the dis­ease. “The mech­a­nism be­hind this im­mune re­sponse is un­known, but our find­ings could in­form fu­ture vac­cine devel­op­ment.” – Daily Mail

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.